Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2018

Jun 8, 2018

29875_dirs_2018-06-08_7a0bd688-99d6-460e-8ecb-59e336fbde02.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2018-06-04

Reporting Person: Hourican Kevin (EVP & President, CVS Pharmacy)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 7709 Direct
Common Stock (restricted) 1232 Direct
Common Stock (restricted) 399 Direct
Common Stock (restricted) 840 Direct
Common Stock (restricted) 2444 Direct
Common Stock (restricted) 2146 Direct
Common Stock (restricted) 3523 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $54.53 2020-04-01 Common Stock (4426) Direct
Stock Option $74.29 2021-04-01 Common Stock (9442) Direct
Stock Option $102.26 2022-04-01 Common Stock (17822) Direct
Stock Option $104.82 2023-04-01 Common Stock (17611) Direct
Stock Option $78.05 2024-04-03 Common Stock (30169) Direct
Stock Option $62.21 2025-04-01 Common Stock (87575) Direct

Footnotes

F1: Consists of remaining Restricted Stock Units awarded pursuant to Issuer's 2017 Incentive Compensation Plan and its Performance-Based Restricted Stock Unit Plan. Restrictions lapse in three equal installments, commening 2/28/2019.

F2: Consists of remaining Restricted Stock Units awarded pursuant to Issuer's Performance-Based Restricted Stock Unit Plan, under its 2010 Incentive Compensation Plan. Restrictions lapse 2/28/2019.

F3: Consists of remaining Restricted Stock Units awarded pursuant to Issuer's Performance-Based Restricted Stock Unit Plan, under its 2010 Incentive Compensation Plan. Restrictions lapse in two equal installments on 2/28/2019 and 2/28/2020.

F4: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 4/1/2019.

F5: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 4/1/2020.

F6: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 4/3/2021.

F7: Remaining options became exercisable in four equal annual installments beginning on 4/1/2014.

F8: Remaining options became exercisable in four equal annual installments beginning on 4/1/2015.

F9: Option became exercisable in four equal annual installments beginning on 4/1/2016.

F10: Option became exercisable in four equal annual installments beginning on 4/1/2017.

F11: Option became exercisable in four equal annual installments beginning on 4/3/2018.

F12: Option becomes exercisable in four equal annual installments beginning on 4/1/2019.